Vitae Pharmaceuticals, Inc.

As an innovative clinical stage biotechnology company, we are developing a robust and growing portfolio of novel product candidates generated by Contour^®, our proprietary computationally-based SBDD platform. Our team of accomplished scientists utilizes Contour^® to rapidly discover highly potent and selective product candidates for validated targets against which the industry has traditionally struggled to develop drugs. We address multiple disease areas including diabetes, Alzheimer’s disease, autoimmune disorders, atopic dermatitis, and acute coronary syndrome.